Castle Biosciences Inc
CSTL· Nasdaq
CSTLCastle Biosciences Inc
Filed Feb 28, 2023 · 10-K · 59 days after period end · 0001447362-23-000038
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $38.34M | $25.04M | $17.30M | $17.64M |
| Net Income | -$20.62M | -$6.43M | -$4.89M | $2.06M |
| EPS Diluted | — | — | -$0.23 | $0.11 |
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 28, 2023 · 59 d after period end
